ADX-102

· Aldeyra Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADX-102, covering 2023-01-09 to 2023-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ADX-102 in Subjects With Allergic Conjunctivitis [Phase 2]